Trustmark National Bank Trust Department’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.2M | Buy |
4,940
+372
| +8% | +$166K | 0.15% | 102 |
|
|
2025
Q1 | $2.21M | Sell |
4,568
-2,209
| -33% | -$1.07M | 0.16% | 104 |
|
|
2024
Q4 | $2.73M | Buy |
6,777
+311
| +5% | +$125K | 0.2% | 91 |
|
|
2024
Q3 | $3.01M | Buy |
6,466
+358
| +6% | +$166K | 0.23% | 86 |
|
|
2024
Q2 | $2.86M | Buy |
6,108
+734
| +14% | +$344K | 0.23% | 89 |
|
|
2024
Q1 | $2.25M | Buy |
5,374
+356
| +7% | +$149K | 0.18% | 96 |
|
|
2023
Q4 | $2.04M | Buy |
5,018
+3,281
| +189% | +$1.34M | 0.19% | 97 |
|
|
2023
Q3 | $604K | Hold |
1,737
| – | – | 0.06% | 171 |
|
|
2023
Q2 | $611K | Buy |
1,737
+15
| +0.9% | +$5.28K | 0.06% | 174 |
|
|
2023
Q1 | $543K | Buy |
1,722
+178
| +12% | +$56.1K | 0.05% | 190 |
|
|
2022
Q4 | $446K | Buy |
+1,544
| New | +$446K | 0.04% | 195 |
|